Home Cart Sign in  
Chemical Structure| 825658-06-8 Chemical Structure| 825658-06-8

Structure of ML335
CAS No.: 825658-06-8

Chemical Structure| 825658-06-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ML335 is a selective activator of both TREK-1 and TREK-2.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ML335

CAS No. :825658-06-8
Formula : C15H14Cl2N2O3S
M.W : 373.25
SMILES Code : O=C(NCC1=CC=C(Cl)C=C1Cl)C2=CC=C(NS(=O)(C)=O)C=C2
MDL No. :MFCD06003481

Safety of ML335

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
BMDMs 5 µM 12 h ML335 inhibited FAs + MSUc-induced NLRP3 inflammasome activation and reduced IL-1β secretion J Transl Med. 2024 Aug 22;22(1):785.
rat articular chondrocytes 1, 5, 10 µM 30 seconds Activation of TREK channels, recording of ion currents Int J Mol Sci. 2024 Jul 18;25(14):7848
COS-7 cells 10 μM Test the effect of ML335 on TWIK2 channel Acta Pharmacol Sin. 2022 Apr;43(4):992-1000
Bone marrow-derived macrophages (BMDMs) 5 µM 12 hours ML335 effectively inhibited the release of IL-1β from MSU crystal-treated BMDMs and reduced NLRP3 inflammasome activation. J Transl Med. 2024 Aug 22;22(1):785
human alveolar epithelial cells (HAEC) 100 μM 72 hours To evaluate the effect of ML335 on HO-induced inflammatory cytokine secretion, it was found that ML335 inhibited the secretion of IL-6, IP-10, CCL-2, and IL-10 Sci Rep. 2020 Dec 15;10(1):22011
mouse alveolar epithelial cells (AT2) 100 μM 24 hours To evaluate the effect of ML335 on HO-induced inflammatory cytokine secretion, it was found that ML335 reduced the secretion of IL-6 and CCL-2 Sci Rep. 2020 Dec 15;10(1):22011
human TREK-1-expressing HEK293 cells 10−5 M 2 min Evaluate the inhibition of ML335-induced TREK-1 activity Int J Mol Sci. 2024 Apr 30;25(9):4907

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Hyperoxia-induced acute lung injury (HALI) model Intra-tracheal injection 100 μM Once daily for 72 hours To evaluate the protective effect of ML335 on hyperoxia-induced lung injury, it was found that ML335 improved lung compliance, histological lung injury scores, broncho-alveolar lavage protein levels and cell counts, and decreased IL-6 and IP-10 concentrations Sci Rep. 2020 Dec 15;10(1):22011

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.68mL

0.54mL

0.27mL

13.40mL

2.68mL

1.34mL

26.79mL

5.36mL

2.68mL

References

 

Historical Records

Categories